Gevokizumab for Active Scleritis

NCT01835132 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

NIH

Sponsor class

Conditions

Scleritis

Interventions

DEVICE: Gevokizumab

Sponsor

National Eye Institute (NEI)

Collaborators

[object Object]